$LLY
ELI LILLY & Co Stock $lly

$lly Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000005947824000118 Filed on April 30, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$11.30B	$8.768B
YoY Change	35.98%	25.98%
Cost Of Revenue	$2.170B	$1.674B
YoY Change	20.07%	2.88%
Gross Profit	$9.133B	$7.095B
YoY Change	40.4%	33.02%
Gross Profit Margin	80.8%	80.91%
Selling, General & Admin	$2.117B	$1.952B
YoY Change	9.97%	11.61%
% of Gross Profit	23.18%	27.52%
Research & Development	$2.711B	$2.523B
YoY Change	15.05%	27.09%
% of Gross Profit	29.69%	35.56%
Depreciation & Amortization	$414.4M	$400.6M
YoY Change	13.13%	10.57%
% of Gross Profit	4.54%	5.65%
Operating Expenses	$4.829B	$4.475B
YoY Change	12.77%	19.84%
Operating Profit	$4.304B	$2.620B
YoY Change	93.63%	63.82%
Interest Expense	-$304.2M	-$117.8M
YoY Change	-352.87%	-214.59%
% of Operating Profit	-7.07%	-4.5%
Other Income/Expense, Net	-$197.6M	$144.9M
YoY Change	436.96%	305.88%
Pretax Income	$3.517B	$2.536B
YoY Change	68.38%	65.79%
Income Tax	$550.2M	$293.2M
% Of Pretax Income	15.64%	11.56%
Net Earnings	$2.967B	$2.243B
YoY Change	68.27%	66.77%
Net Earnings / Revenue	26.25%	25.58%
Basic Earnings Per Share	$3.29	$2.49
Diluted Earnings Per Share	$3.28	$2.48
COMMON SHARES
Basic Shares Outstanding	950.4M shares	950.2M shares
Diluted Shares Outstanding	904.2M shares	903.8M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.364B	$2.586B
YoY Change	18.91%	-29.52%
Cash & Equivalents	$3.224B	$2.460B
Short-Term Investments	$140.4M	$126.1M
Other Short-Term Assets	$142.2M	$6.487B
YoY Change	-96.86%	81.45%
Inventory	$6.482B	$6.102B
Prepaid Expenses	$7.138B	$6.349B
Receivables	$11.03B	$7.886B
Other Receivables	$2.051B	$2.128B
Total Short-Term Assets	$30.20B	$25.19B
YoY Change	41.59%	21.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.83B	$13.62B
YoY Change	31.5%	29.18%
Goodwill	$5.768B	$4.940B
YoY Change	41.42%	21.27%
Intangibles	$6.636B	$6.762B
YoY Change	-3.87%	-4.58%
Long-Term Investments	$2.878B	$3.087B
YoY Change	4.83%	12.23%
Other Assets	$4.904B	$10.34B
YoY Change	4.97%	130.43%
Total Long-Term Assets	$41.67B	$38.75B
YoY Change	24.45%	19.79%
TOTAL ASSETS
Total Short-Term Assets	$30.20B	$25.19B
Total Long-Term Assets	$41.67B	$38.75B
Total Assets	$71.87B	$63.94B
YoY Change	31.12%	20.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.925B	$2.474B
YoY Change	18.21%	22.71%
Accrued Expenses	$13.62B	$10.27B
YoY Change	1469.1%	1288.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.162B	$1.652B
YoY Change	680.17%	53174.19%
Total Short-Term Liabilities	$27.12B	$18.60B
YoY Change	43.38%	16.17%
LONG-TERM LIABILITIES
Long-Term Debt	$23.73B	$24.56B
YoY Change	30.69%	30.08%
Other Long-Term Liabilities	$2.471B	$7.888B
YoY Change	26.59%	332.82%
Total Long-Term Liabilities	$31.12B	$32.45B
YoY Change	25.73%	25.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.12B	$18.60B
Total Long-Term Liabilities	$31.12B	$32.45B
Total Liabilities	$58.24B	$51.13B
YoY Change	33.38%	22.12%
SHAREHOLDERS EQUITY
Retained Earnings	$13.18B	$12.55B
YoY Change	27.1%	18.0%
Common Stock	$7.808B	$7.604B
YoY Change	3.53%	2.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.56B	$12.81B
YoY Change
Total Liabilities & Shareholders Equity	$71.87B	$63.94B
YoY Change	31.12%	20.28%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$2.967B	$2.243B
YoY Change	68.27%	66.77%
Depreciation, Depletion And Amortization	$414.4M	$400.6M
YoY Change	13.13%	10.57%
Cash From Operating Activities	$1.466B	$1.166B
YoY Change	132.03%	-32.62%
INVESTING ACTIVITIES
Capital Expenditures	$1.403B	$1.083B
YoY Change	67.74%	19.85%
Acquisitions
YoY Change
Other Investing Activities	-$795.9M	-$94.80M
YoY Change	-311.0%	135.24%
Cash From Investing Activities	-$2.199B	-$1.178B
YoY Change	378.92%	70.96%
FINANCING ACTIVITIES
Cash Dividend Paid		$1.169B
YoY Change		14.94%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.556B	-311.3M
YoY Change	-250.52%	-175.5%
NET CHANGE
Cash From Operating Activities	1.466B	1.166B
Cash From Investing Activities	-2.199B	-1.178B
Cash From Financing Activities	1.556B	-311.3M
Net Change In Cash	823.0M	-322.9M
YoY Change	-195.63%	-121.83%
FREE CASH FLOW
Cash From Operating Activities	$1.466B	$1.166B
Capital Expenditures	$1.403B	$1.083B
Free Cash Flow	$63.40M	$83.20M
YoY Change	-131.02%	-89.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1673500000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1626700000	usd
CY2024Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	2522800000	usd
CY2023Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1985100000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1952200000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1749200000	usd
CY2024Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	110500000	usd
CY2023Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	105000000.0	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	27100000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	35700000	usd
CY2024Q1	lly	Cost Of Sales Operating Expenses And Other Net CostOfSalesOperatingExpensesAndOtherNet	6231900000	usd
CY2023Q1	lly	Cost Of Sales Operating Expenses And Other Net CostOfSalesOperatingExpensesAndOtherNet	5430300000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2536100000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1529700000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	293200000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	184800000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2242900000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1344900000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.49
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.48
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	900800000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	901000000.0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	903800000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	903300000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2242900000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1344900000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	27500000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	67300000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2270400000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1412200000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2460200000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2818600000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	126100000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	109100000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	14300000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	14800000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7885600000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9090500000	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2127900000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2245700000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6101800000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	5772800000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6348600000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5540800000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	138600000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	149500000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	25188800000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	25727000000	usd
CY2024Q1	us-gaap	Long Term Investments LongTermInvestments	3086900000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	3052200000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4939600000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4939700000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6762200000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6906600000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5633900000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5477300000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11235000000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11099300000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13624000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12913600000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4708100000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4989900000	usd
CY2024Q1	us-gaap	Assets Assets	63943500000	usd
CY2023Q4	us-gaap	Assets Assets	64006300000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	1651500000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	6904500000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2473700000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2598800000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	844200000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1650400000	usd
CY2024Q1	lly	Sales Rebates And Discounts SalesRebatesAndDiscounts	9429600000	usd
CY2023Q4	lly	Sales Rebates And Discounts SalesRebatesAndDiscounts	11689000000	usd
CY2024Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	0	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1169200000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4199100000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3281300000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	18598100000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27293200000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24559900000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18320800000	usd
CY2024Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	1427900000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	1438800000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	4189400000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3849200000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2270800000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2240600000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	32448000000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	25849400000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	594200000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	593600000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7009500000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7250400000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12553900000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10312300000	usd
CY2024Q1	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	3013200000	usd
CY2023Q4	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	3013200000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4299500000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4327000000	usd
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	32700000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	44200000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	12812200000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10771900000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	85200000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	91800000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12897400000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10863700000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63943500000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64006300000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2500000000	usd
CY2021Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2242900000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1344900000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	400600000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	362300000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	279000000.0	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	559400000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	159400000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	131200000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	15800000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-14200000	usd
CY2024Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	110500000	usd
CY2023Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	105000000.0	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1751200000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-164100000	usd
CY2024Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	298600000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	168300000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1166000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1730600000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	986300000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	668500000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	41400000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	61500000	usd
CY2024Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	24400000	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	23000000.0	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	70500000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	281900000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	117100000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	146000000.0	usd
CY2024Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	96500000	usd
CY2023Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	235000000.0	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	65200000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-40300000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1177600000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-688800000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1169200000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1017200000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-5204800000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-1498000000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	6452500000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3958500000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	750000000.0	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-389800000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-281000000.0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-311300000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	412300000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-35500000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24800000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-358400000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1478900000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2818600000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2067000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2460200000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3545900000	usd
CY2024Q1	us-gaap	Revenues Revenues	8768000000	usd
CY2023Q1	us-gaap	Revenues Revenues	6960000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	186700000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	193600000	usd
CY2024Q1	us-gaap	Revenues Revenues	8768000000	usd
CY2023Q1	us-gaap	Revenues Revenues	6960000000	usd
CY2024Q1	us-gaap	Revenues Revenues	8768000000	usd
CY2023Q1	us-gaap	Revenues Revenues	6960000000	usd
CY2024Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	110500000	usd
CY2023Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	105000000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	699600000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	791700000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	3611900000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3248600000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1693800000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1630100000	usd
CY2024Q1	us-gaap	Inventory Gross InventoryGross	6005300000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	5670400000	usd
CY2024Q1	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	-96500000	usd
CY2023Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	-102400000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6101800000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	5772800000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	16000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-13700000	usd
CY2024Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments	880000000	usd
CY2024Q1	lly	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Commitments Payment Period FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommitmentsPaymentPeriod	P10Y
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	650200000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	83700000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	222400000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	98300000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	245800000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1900000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3400000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	42500000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	37900000	usd
CY2024Q1	lly	Debt Securities Available For Sale Unrealized Gain Position DebtSecuritiesAvailableForSaleUnrealizedGainPosition	111800000	usd
CY2023Q4	lly	Debt Securities Available For Sale Unrealized Gain Position DebtSecuritiesAvailableForSaleUnrealizedGainPosition	159200000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	477900000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	452000000.0	usd
CY2024Q1	lly	Proceeds From Sale Of Equity And Available For Sale Securities ProceedsFromSaleOfEquityAndAvailableForSaleSecurities	24400000	usd
CY2023Q1	lly	Proceeds From Sale Of Equity And Available For Sale Securities ProceedsFromSaleOfEquityAndAvailableForSaleSecurities	27600000	usd
CY2024Q1	us-gaap	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized	399000000	usd
CY2023Q4	us-gaap	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized	431900000	usd
CY2024Q1	us-gaap	Average Remaining Maturity Of Foreign Currency Derivatives1 AverageRemainingMaturityOfForeignCurrencyDerivatives1	P12M
CY2024Q1	us-gaap	Maximum Remaining Maturity Of Foreign Currency Derivatives1 MaximumRemainingMaturityOfForeignCurrencyDerivatives1	P180D
CY2024Q1	us-gaap	Translation Adjustment For Net Investment Hedge Net Of Tax TranslationAdjustmentForNetInvestmentHedgeNetOfTax	5540000000	usd
CY2023Q4	us-gaap	Translation Adjustment For Net Investment Hedge Net Of Tax TranslationAdjustmentForNetInvestmentHedgeNetOfTax	5670000000	usd
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.08
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-5400000	usd
CY2024Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-32900000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	27500000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	76800000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	9500000	usd
CY2024Q1	lly	Derivative Instruments Gain Loss Recognized DerivativeInstrumentsGainLossRecognized	-88800000	usd
CY2023Q1	lly	Derivative Instruments Gain Loss Recognized DerivativeInstrumentsGainLossRecognized	61900000	usd
CY2024Q1	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	-5400000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.116
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.121
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	67300000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	64800000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-36000000.0	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	179600000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	102800000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	45800000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	34200000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	16000000.0	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-13700000	usd
CY2024Q1	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-116100000	usd
CY2023Q1	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-115800000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	28800000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2200000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	27100000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	35700000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0000059478-24-000118-index-headers.html	Edgar Link	pending
0000059478-24-000118-index.html	Edgar Link	pending
0000059478-24-000118.txt	Edgar Link	pending
0000059478-24-000118-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lly-03312024x10qxexhibit311.htm	Edgar Link	pending
lly-03312024x10qxexhibit312.htm	Edgar Link	pending
lly-03312024x10qxexhibit32.htm	Edgar Link	pending
lly-20240331.htm	Edgar Link	pending
lly-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lly-20240331_def.xml	Edgar Link	unprocessable
lly-20240331_lab.xml	Edgar Link	unprocessable
lly-20240331_pre.xml	Edgar Link	unprocessable
lly-20240331_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lly-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LLY
ELI LILLY & Co Stock $lly

2024 Q2 Form 10-Q Financial Statement

#000005947824000118 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LLY ELI LILLY & Co Stock $lly

2024 Q2 Form 10-Q Financial Statement

#000005947824000118 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LLY
ELI LILLY & Co Stock $lly